NCT06508125

Cross-linked and Non-cross-linked Hyaluronic Acid in Subdeltoid Bursitis

Comparing the Efficacy of Cross-Linked and Non-Cross-Linked Hyaluronic Acid in Treating Subdeltoid Bursitis: A Double-Blind, Randomized Clinical Trial

• Status: Not Yet Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 52 (estimated)
• Sponsor: Taipei Medical University · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study aims to compare the efficacy of different structures of hyaluronic acid, namely cross-linked and non-cross-linked hyaluronic acid, in treating subdeltoid bursitis.

Detailed description

A double-blind, randomized clinical trial will be conducted to collect 52 patients with subdeltoid bursitis. The patients will be injected with cross-linked or non-cross-linked hyaluronic acid under ultrasound guidance. Before treatment, one week after treatment (i.e., one week after injection), one month after treatment, and three months after treatment to detect shoulder pain (visual analog scale; pressure ergometer to measure pain pressure threshold), function (including Disabilities of the Arm, Shoulder, and Hand: DASH and Shoulder Pain and Disability Index: SPADI), quality of life (Brief version of the World Health Organization Quality of Life Scale: WHOQOL-BREF) will be arranged.

Conditions

• Subdeltoid Bursitis
• Hyaluronic Acid

Interventions

Type	Name	Description
DRUG	cross-linked hyaluronic acid	cross-linked hyaluronic acid injection with physical therapy
DRUG	non-cross-linked hyaluronic acid	non-cross-linked hyaluronic acid injection with physical therapy

Timeline

• Start date: 2024-07-25
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2024-07-18
• Last updated: 2024-07-19

Locations

1 site across 1 country: Taiwan